United Therapeutics Co-Pay Assistance Program Patient Portal

Tyvaso®

Orenitram®

Remodulin®

Adcirca®

| RECOVER

Click on the product for which you would like to enroll

Recover Co-Pay Id Number

Redemption Terms & Conditions

Please register and activate a Co-Pay Identification Number which can be used for your prescription of:

Adcirca (tadalafil) tablets
Orenitram (treprostinil) extended release tablets
Remodulin (treprostinil) injection
Tyvaso (treprostinil) inhalation solution and Tyvaso DPI (treprostinil) inhalation powder

BY REGISTERING IN THIS PROGRAM, YOU UNDERSTAND AND AGREE TO COMPLY WITH THE ELIGIBILITY REQUIREMENTS AND TERMS OF USE SET FORTH BELOW.

Under these Co-Pay Assistance Programs ("Programs"), most eligible patients pay a small Out of Pocket for their monthly prescription.

ELIGIBILITY REQUIREMENTS

The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA approved indication.
Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible.
Eligible patients must be a resident of the US or Puerto Rico.
Void where prohibited taxed or restricted by law.
You must be 18 years or older to use this Program.

ADDITIONAL TERMS AND CONDITIONS

This Program is only valid for cost of the drug Adcirca, Orenitram, Remodulin, or Tyvaso and Tyvaso DPI and is not applicable to any related supplies or other medical expenses associated with administering the product.
This Program is not conditioned on any past, present or future purchase, including refills.
The patient confirms that this Program is consistent with patient's insurance. The patient is responsible for reporting the receipt of all Program benefits as required by the insurance company.
This Program is not insurance and is not intended to substitute for insurance.
Limit 1 (one) Co-Pay Identification Number per patient.
This ID number is non-transferable and has no value.
Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the Patient through this offer.
United Therapeutics reserves the right to modify or terminate this program at any time without notice.
By enrolling in the Program, you agree that your personal information may be used by United Therapeutics and its affiliates to send you information about United Therapeutics products, programs, support and services related to your condition and contact you in connection with your participation in the Program and as provided in our Privacy Policy. United Therapeutics respects the privacy of your personal information and you may unsubscribe from our programs at any time by calling 1-877-864-8437.

Orenitram®, Remodulin®, and Tyvaso® are registered trademarks of United Therapeutics Corporation, and Tyvaso DPI™ is a trademark of United Therapeutics Corporation. Adcirca® is a registered trademark of Eli Lilly and Company. All other trademarks and registered trademarks are the property of their respective owners.

Learn More

This site is intended for use by US and Puerto Rico residents only.